Dr. Julie Dumond is the Director of the Pharmacometrics Core.  She received her Doctor of Pharmacy degree from the University of Michigan in 2004.  After completing a pharmacy practice residency at Borgess Health in Kalamazoo, Michigan, Dr. Dumond completed the HIV Pharmacology Fellowship at the UNC Eshelman School of Pharmacy in 2007.  Prior to returning to Carolina to head the Pharmacometrics Core, Dr. Dumond was an assistant professor in the inaugural faculty of the Gatton College of Pharmacy at East Tennessee State University.  She became a Board Certified Pharmacotherapy Specialist (BCPS) in 2006, and an HIV Subject Matter Expert (AAHIVE) in 2009.

Dr. Dumond's research interests are focused on the pharmacokinetics and pharmacodynamics of antiretroviral drugs used to treat and prevent HIV infection.  She maintains a clinical practice at the UNC Infectious Diseases Clinic, and is involved in the education of professional pharmacy students, graduate students, and pharmacy fellows.  

Recent Publications:

Kwara A, Tashima K, Dumond J, Poethke P, Kurpewski J, Kashuba A, Court MH, Greenblatt DH.  Modest but Variable Effect of Rifampin on Steady-State Plasma Pharmacokinetics of Efavirenz in Healthy African-American and Caucasian Volunteers.  Antimicrob Agents Chemo 2011; Apr 25. [Epub ahead of print].

Brown KC, Patterson KB, Malone SA, Shaheen NJ, Prince HMA, Dumond JB, Spacek M, Heidt PE, Cohen MS, and Kashuba ADM.  Single and Multiple Dose Pharmacokinetics of Maraviroc in Saliva, Semen, and Rectal Tissue of Healthy HIV-Negative Men.  J Infect Dis; 2011;203:1484-90. 

Dumond JB, Vourvahis M, Rezk NL, Patterson KB, Tien H, White N, Jennings S, Choi SO, Li J, Wagner MJ, La I, Drulak M, Sabo JP, Castles MA, MacGregor TR, Kashuba ADM. A Phenotype-Genotype Approach to Predicting CYP450 and P-glycoprotein Drug Interactions with the Mixed Inhibitor/Inducer Tipranavir/ritonavir.  Clinical Pharmacol Ther 2010; 87:735-42.

Dumond JB, Patterson KB, Pecha AL, Werner RE, Andrews E, Damle B, Tressler R, Worsley J, Kashuba ADM.  Maraviroc Concentrates in Cervicovaginal Fluid and Vaginal Tissue of HIV Negative Women.  J Acquir Immune Defic Syndr.2009; 51:546-553.   

Yeh RF, Rezk NL, Kashuba ADM, Dumond JB, Tappouni HL, Tien H, Chen Y, Vourvahis M, Horton AL, Fiscus SA, Patterson KB.   Genital Tract, Cord Blood, and Amniotic Fluid Exposures of 6 Antiretroviral Drugs During Pregnancy and Postpartum.  Antimicrob Agents Chemo 2009; 53:2367-2374.

Dumond JB, Reddy YS, Troiani L, Rodriguez JF, Bridges AS, Fiscus SA, Yuen GJ, Cohen MS, Kashuba AD.  Differential Extracellular and Intracellular Concentrations of Zidovudine and Lamivudine In Semen and Plasma of HIV-1 Infected Men.  J Acquir Immune Defic Syndr. 2008; 48:156-162.

Dumond JB, Yeh RF, Patterson KB, Corbett AH, Jung BH, Rezk NL, Bridges AS, Stewart PW, Cohen MS, Kashuba ADM.  Antiretroviral Drug Exposure in the Female Genital Tract: Implications for Oral Pre- and Post-Exposure Prophylaxis.  AIDS 2007; 21: 1899-1907.